Target intelligence / Profile preview

Pseudogene similar to part of breast cancer antigen NY-BR-1 (null)

Target: null
Molecular classification: Pseudogene, Other (not protein-coding, not an enzyme, receptor, transporter, etc.)

Overview

ENSG00000215409 is a human pseudogene annotated as "pseudogene similar to part of breast cancer antigen NY-BR-1 (NY-BR-1)", also known as AL355493.1, mapped to chromosome 10. Pseudogenes are DNA sequences similar to known genes but are generally nonfunctional due to mutations, deletions, or truncations[3][7][9][11]. This pseudogene resembles the NY-BR-1 locus, which is a protein differentiation antigen associated with breast cancer, but ENSG00000215409 itself does not encode the protein and has no known functional role, disease association, or therapeutic relevance. If searching for a therapeutic target or clinically relevant molecule, NY-BR-1 (ANKRD30A) should be referenced instead[7][12].

Other names: AL355493.1Pseudogene similar to part of breast cancer antigen NY-BR-1

Mechanism of action

None (No mechanism of action relevant for drugs since it is a pseudogene.)

Biological functions

None (As a pseudogene, it does not encode a protein nor known biological functions[3][7][9][11].)

Disease associations

None (No reported direct role for the pseudogene in disease. The protein-coding locus for NY-BR-1/ANKRD30A is associated with breast cancer, but not this pseudogene.)

Safety considerations

None (No therapeutic applicability or known safety concerns for this pseudogene[3][7][9][11].)

Interacting drugs

None (No drugs target this pseudogene[3][7][9][11]. Drugs may target the protein ANKRD30A/NY-BR-1, but that is a different, active gene[12].)

Biomarkers

None (The pseudogene is not used as a biomarker[3][7][9][11]. NY-BR-1/ANKRD30A protein itself is a candidate biomarker in breast cancer, but this pseudogene is not.)

Beyond the preview

Go deeper on Pseudogene similar to part of breast cancer antigen NY-BR-1 (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene similar to part of breast cancer antigen NY-BR-1 (null).

Explore the full profile